Donald J. Hillebrand
Member of Scientific Advisory BoardDr. Donald J. Hillebrand is Member of Scientific Advisory Board of Sigyn Therapeutics, Inc. since April 2022. He is the Associate Medical Director of Liver Transplantation at Saint Luke's Hospital of Kansas City and Associate Professor of Medicine at the University of Missouri Kansas City (UMKC). He has served as a Principal Investigator in clinical studies of extracorporeal technologies. He has authored more Papers Published or In Press/Preparation and books and/or book chapters. He is currently on the Editorial Board, ASAIO Journal, Section Editor ASATO Journal-Liver Transplantation, Website Editor ASAIO Artificial Liver Section and Reviewer, European Journal of Gastroenterology & Hepatology. He graduated with distinction in Microbiology from Iowa State University. He did his residency in Internal Medicine at Iowa State University Hospitals and Clinics and fellowships in Gastroenterology/Hepatology and Liver Transplantation at Iowa State University Hospitals and Clinics.
Positions
- Company NameSigyn Therapeutics, Inc.Stock CodeSIGYPositionMember of Scientific Advisory Board
